Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (46)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

  3. Systematic influenza screening in cardiac intensive care units during the influenza season: A prospective study in Spain

    International Journal of Infectious Diseases, Vol. 136, pp. 37-42

2022

  1. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Mycoses, Vol. 65, Núm. 3, pp. 362-373

  2. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  3. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Linezolid for infective endocarditis: A structured approach based on a national database experience

    Medicine (United States), Vol. 100, Núm. 51

  2. Overview of virus and cancer relationships. Position paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 525-555

2020

  1. Biomarkers of fungal infection: Expert opinion on the current situation

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 1, pp. 1-10

  2. Recommendations for the diagnosis and treatment of clostridioides difficile infection: An official clinical practice guideline of the spanish society of chemotherapy (SEQ), spanish society of internal medicine (SEMI) and the working group of postoperative infection of the spanish society of anesthesia and reanimation (SEDAR)

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 2, pp. 151-175

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Dalbavancin in the treatment of different gram-positive infections: a real-life experience

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577

  2. Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial

    Clinical Microbiology and Infection

  3. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

2017

  1. Candidemia in non-ICU surgical wards: Comparison with medical wards

    PLoS ONE, Vol. 12, Núm. 10

  2. Endocarditis caused by anaerobic bacteria

    Anaerobe, Vol. 47, pp. 33-38

  3. Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort

    Medicine (United States), Vol. 96, Núm. 38

  4. Performance of a quantitative pcrbased assay and beta-D-glucan detection for diagnosis of invasive candidiasis in very-low-birth-weight preterm neonatal patients (candineo study)

    Journal of Clinical Microbiology, Vol. 55, Núm. 9, pp. 2752-2764

  5. Quality of the aetiological diagnosis of ventilator-associated pneumonia in Spain in the opinion of intensive care specialists and microbiologists

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 3, pp. 153-164

2016

  1. Endocarditis in patients with ascending aortic prosthetic graft: A case series from a national multicentre registry

    European Journal of Cardio-thoracic Surgery, Vol. 50, Núm. 6, pp. 1149-1157